Hsbc Holdings PLC Arcturus Therapeutics Holdings Inc. Transaction History
Hsbc Holdings PLC
- $176 Billion
- Q3 2025
A detailed history of Hsbc Holdings PLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 23,983 shares of ARCT stock, worth $174,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,983
Previous 32,368
25.91%
Holding current value
$174,356
Previous $421,000
4.99%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ARCT
# of Institutions
173Shares Held
26MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...